During the past decade, Vinzenz von Paul Kliniken gGmbH Marienhospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vinzenz von Paul Kliniken gGmbH Marienhospital" are "Acute Myeloid Leukemia (AML)" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Vinzenz von Paul Kliniken gGmbH Marienhospital" in a lesser frequency.

Most popular intervention types in "Vinzenz von Paul Kliniken gGmbH Marienhospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (1 trials), "Dasatinib" (1 trials), "Daunorubicin" (1 trials), "Idarubicin" (1 trials) and "Palbociclib + endocrine therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vinzenz von Paul Kliniken gGmbH Marienhospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vinzenz von Paul Kliniken gGmbH Marienhospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vinzenz von Paul Kliniken gGmbH Marienhospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vinzenz von Paul Kliniken gGmbH Marienhospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".